Recombinant Canine FGF12

• Cat.No.: FGF12-434C
• Product Overview: Recombinant Canine FGF12 (Glu2-Thr181), fused with a N-terminal Met, was produced in E. coli.

Specification

• Source: E. coli
• Species: Canine
• Predicted N Terminal: Met
• Form: Lyophilized from sterile PBS, pH 7.4.Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization.
• Molecular Mass: The recombinant canine FGF12 comprises 181 amino acids and has a predicted molecular mass of 20.4 kDa. The apparent molecular mass of the protein is approximately 20 kDa in SDS-PAGE under reducing conditions due to glycosylation.
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method.
• Purity: >90 % as determined by SDS-PAGE
• Stability: Samples are stable for up to twelve months from date of receipt at -70ºC.
• Storage: Store it under sterile conditions at -20ºC~-70ºC. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
• Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution. Centrifuge the vial at 4℃ before opening to recover the entire contents.

Gene Information

• Gene Name: FGF12 fibroblast growth factor 12 [ Canis lupus familiaris (dog) ]
• Official Symbol: FGF12
• Synonyms: FGF12; fibroblast growth factor 12
• Gene ID: 478676
• mRNA Refseq: XM_003434129
• Protein Refseq: XP_003434177
• Chromosome Location: 34
• Pathway: MAPK signaling pathway; Melanoma; PI3K-Akt signaling pathway